Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

BBH VanEck Vectors Biotech ETF

  • Fund Description

    VanEck Vectors Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 08/29/16

    • 30-Day SEC Yield1

      0.31%
    • Total Net Assets

      $607.8M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.40%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/16/2016
  • Portfolio Composition (%)
    as of 08/29/16

    • % of Net Assets
    • Stocks

      100.04
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.04
  • Daily HoldingsDaily Holdings (%) as of 08/29/16

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Amgen Inc
    AMGN US
    504,311
    86,494,38014.23
    Gilead Sciences Inc
    GILD US
    906,010
    70,822,80211.65
    Celgene Corp
    CELG US
    603,211
    65,116,62710.71
    Biogen Inc
    BIIB US
    143,135
    43,817,9187.21
    Medivation Inc
    MDVN US
    432,286
    34,703,9205.71
    Illumina Inc
    ILMN US
    178,764
    30,464,9615.01
    Regeneron Pharmaceuticals Inc
    REGN US
    74,179
    29,625,6094.87
    Biomarin Pharmaceutical Inc
    BMRN US
    308,766
    29,561,2574.86
    Vertex Pharmaceuticals Inc
    VRTX US
    274,523
    26,612,2604.38
    Incyte Corp
    INCY US
    304,738
    24,784,3424.08
    Alexion Pharmaceuticals Inc
    ALXN US
    186,981
    23,931,6983.94
    Quintiles Transnational Holdings Inc
    Q US
    279,704
    21,654,6843.56
    Qiagen Nv
    QGEN US
    664,614
    17,858,1782.94
    Grifols Sa
    GRFS US
    849,241
    13,604,8412.24
    United Therapeutics Corp
    UTHR US
    107,651
    13,137,7282.16
    Charles River Laboratories Internationa
    CRL US
    153,257
    12,876,6532.12
    Alnylam Pharmaceuticals Inc
    ALNY US
    166,088
    11,885,2571.96
    Alkermes Plc
    ALKS US
    227,561
    10,119,6381.66
    Neurocrine Biosciences Inc
    NBIX US
    202,540
    9,987,2471.64
    Seattle Genetics Inc
    SGEN US
    194,348
    8,815,6251.45
    Ionis Pharmaceuticals Inc
    IONS US
    248,820
    7,544,2221.24
    Cepheid
    CPHD US
    161,698
    5,670,7490.93
    Intercept Pharmaceuticals Inc
    ICPT US
    33,137
    5,023,2380.83
    Bluebird Bio Inc
    BLUE US
    52,688
    2,731,8730.45
    Puma Biotechnology Inc
    PBYI US
    20,595
    1,217,5760.20
    Other/Cash
    --
    --
    -213,618-0.04
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.